Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

 Log in / Sign up

Contact lens study checks how well they work for nearsighted and farsighted people

NCT ID NCT07276347

Symptom relief Sponsor: CooperVision International Limited (CVIL) Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed This study
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study looked at how well contact lenses perform and how comfortable people find them. It included 36 adults who already wear soft contact lenses and have nearsightedness or farsightedness. Participants wore the lenses and had their vision tested after 10 hours.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

36 people

The number who actually took part.

Started

Nov 2025

Finished

Dec 2025

Lead sponsor

A company

The lead sponsor is a pharmaceutical, biotech, or medical-device company.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

18 to 45 years

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: 1. Age 18 to 45 years (inclusive) 2. Habitual soft spherical contact lens wearer (current prescription) 3. Refractive error of -6.00 to -0.50DS or +0.50 to +6.00DS and less than or equal to 0.75DC as vertexed to the corneal plane 4. Anisometropia no greater than 1.50D, based on vertexed manifest refraction spherical equivalent 5. Can achieve visual acuity of at least 20/25 in each eye with spherical equivalent manifest refraction Exclusion Criteria: 1. Active anterior segment infection, inflammation or abnormality that would contraindicate contact lens wear 2. Use of systemic or ocular medication that would contraindicate contact lens wear 3. Used gas permeable/hard contact lenses (including orthokeratology) in the previous 3 months 4. Participation in a contact lens or lens care product trial in the previous 30 days

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Hyperopia are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

hyperopia myopia

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Hyperopia Myopia

Contacts and locations

Locations

  • Indiana University

    Bloomington, Indiana, 47405, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.